ZertifikateAwards 2021/2022: Bitte stimmen Sie für finanzen.net zero und finanzen.net ab und gewinnen Sie eine Reise nach Berlin! -w-
17.09.2021 15:35

Philip Morris (PM) Secures More than 74% Stake in Vectura

Folgen
Werbung
Philip Morris International Inc. PM is focusing on plans to expand Beyond Nicotine products. Moving along these lines, the company announced that its offer to acquire Vectura Group plc has become unconditional as it has secured more than 74% of the latter’s shares. This makes Philip Morris a majority stakeholder of Vectura. The acquired shares are in excess of the 50% required as per the terms of acceptance. The company also confirmed that all other conditions of the offer have been satisfied or waived. Vectura, which reported net revenues of almost $245 million in 2020, is the provider of innovative inhaled drug delivery solutions.With the acquisition, Philip Morris expects to accelerate Vectura’s geographical footprint, develop proprietary inhaled therapeutic products along with working on the existing contract development and manufacturing organization (CDMO) business. Management highlighted that the move bodes well amid the fast-growing inhaled therapeutics market. The company is committed toward making higher investments in R&D to support Vectura’s differentiated technologies and development expertise toward delivery of complex inhaled therapeutics. By making such investments, Philip Morris hopes to amplify growth in its Beyond Nicotine strategy.The transaction price reflects a multiple of roughly 15 times Vectura’s 2020 EBITDA. Philip Morris does not expect to record any material impact from the buyout on its 2021 adjusted earnings per share.Image Source: Zacks Investment ResearchBeyond Nicotine Strategy Looks PromisingPhilip Morris has been firm on its ambitious plans to expand the Beyond Nicotine products. In February 2021, the company revealed plans of generating at least $1 billion in annual net revenues from the Beyond Nicotine sources by 2025. The initiative leverages its expertise in life sciences, inhalation technology and natural ingredients among others. The strategy is based around two growth areas — inhaled therapeutics development as well as commercializing scientifically substantiated consumer health products and solutions.In efforts to boost the Beyond Nicotine portfolio, Philip Morris recently acquired a well-known developer as well as manufacturer of pharmaceutical and well-being products — Fertin Pharma A/S ("Fertin Pharma"). With the help of Fertin Pharma’s impressive technologies, solid capabilities and efficient workforce, Philip Morris expects to make innovative oral delivery products. The acquisition will accelerate the company’s presence in the rapidly-growing modern oral category. Philip Morris can leverage Fertin Pharma’s oral delivery platforms to develop self-care wellness items like over-the-counter solutions and supplements.In August, Philip Morris acquired OtiTopic, a respiratory drug development company based in the United States, as part of its Beyond Nicotine strategy. The acquisition of OtiTopic is expected to further strengthen the company’s ability in R&D of aerosolization and inhalable treatments.Shares of the Zacks Rank #3 (Hold) company have gained 24.2% so far this year compared with the industry’s rise of 17%.Top 3 Consumer Staple PicksVector Group Ltd. VGR, sporting a Zacks Rank #1 (Strong Buy), has a trailing four-quarter earnings surprise of 73%, on average. You can see the complete list of today’s Zacks #1 Rank stocks here.Medifast, Inc. MED, currently carrying a Zacks Rank #2 (Buy), has a trailing four-quarter earnings surprise of 16%, on average.Sysco Corporation SYY, currently carrying a Zacks Rank #2, has a trailing four-quarter earnings surprise of 13.3%, on average.Bitcoin, Like the Internet Itself, Could Change EverythingBlockchain and cryptocurrency has sparked one of the most exciting discussion topics of a generation. Some call it the “Internet of Money” and predict it could change the way money works forever. If true, it could do to banks what Netflix did to Blockbuster and Amazon did to Sears. Experts agree we’re still in the early stages of this technology, and as it grows, it will create several investing opportunities.Zacks’ has just revealed 3 companies that can help investors capitalize on the explosive profit potential of Bitcoin and the other cryptocurrencies with significantly less volatility than buying them directly.See 3 Crypto-Related Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Philip Morris International Inc. (PM): Free Stock Analysis Report Sysco Corporation (SYY): Free Stock Analysis Report Vector Group Ltd. (VGR): Free Stock Analysis Report MEDIFAST INC (MED): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
Weiter zum vollständigen Artikel bei "Zacks"
Quelle: Zacks

Nachrichten zu Philip Morris Inc.

  • Relevant
  • Alle
  • vom Unternehmen
  • Peer Group
  • ?

Um Ihnen die Übersicht über die große Anzahl an Nachrichten, die jeden Tag für ein Unternehmen erscheinen, etwas zu erleichtern, haben wir den Nachrichtenfeed in folgende Kategorien aufgeteilt:

Relevant: Nachrichten von ausgesuchten Quellen, die sich im Speziellen mit diesem Unternehmen befassen

Alle: Alle Nachrichten, die dieses Unternehmen betreffen. Z.B. auch Marktberichte die außerdem auch andere Unternehmen betreffen

vom Unternehmen: Nachrichten und Adhoc-Meldungen, die vom Unternehmen selbst veröffentlicht werden

Peer Group: Nachrichten von Unternehmen, die zur Peer Group gehören

Analysen zu Philip Morris Inc.

  • Alle
  • Buy
  • Hold
  • Sell
  • ?
28.08.2019Philip Morris NeutralJP Morgan Chase & Co.
28.08.2019Philip Morris UnderperformCredit Suisse Group
19.07.2019Philip Morris OverweightBarclays Capital
23.05.2019Philip Morris Equal WeightBarclays Capital
20.07.2018Philip Morris BuyStifel, Nicolaus & Co., Inc.
19.07.2019Philip Morris OverweightBarclays Capital
20.07.2018Philip Morris BuyStifel, Nicolaus & Co., Inc.
10.04.2018Philip Morris BuyDeutsche Bank AG
16.10.2015Philip Morris International OverweightBarclays Capital
21.03.2013Philip Morris International kaufenJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
28.08.2019Philip Morris NeutralJP Morgan Chase & Co.
23.05.2019Philip Morris Equal WeightBarclays Capital
20.07.2018Philip Morris Market PerformCowen and Company, LLC
13.04.2015Philip Morris International HoldArgus Research Company
22.10.2012Philip Morris International holdJefferies & Company Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Philip Morris Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"

Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"

Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen
Werbung
Werbung
Werbung
Werbung
Börse Stuttgart Anlegerclub
Werbung

Heute im Fokus

Dow letztlich fester -- DAX schließt im Plus -- Software AG senkt Ausblick für Digital -- Delivery Hero steigt bei Gorillas ein -- GameStop, J&J, Apple, Munich Re, TeamViewer im Fokus

Amazon springt auf 3D-Audio-Zug auf. RWE will in Großbritannien bis 2030 rund 15 Milliarden Pfund investieren. E.ON nimmt Neukundengeschäft mit Gas wieder auf. Procter & Gamble veranlasst wegen steigender Kosten höhere Preise. Travelers übertrifft Erwartungen im dritten Quartal. Roche-Partner Atea kann mit Corona-Pille Ziele nicht erreichen. JENOPTIK übernimmt Berliner Glas Medical und Swissoptic.

Umfrage

Wo steht der DAX zum Jahresende?

finanzen.net zero
finanzen.net zero

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln